Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study

被引：0
作者：
Lacson, John Charles A. [1 ]
Ma, Huiyan [2 ]
Lee, Eunjung [1 ]
Neuhausen, Susan L. [2 ]
Anton-Culver, Hoda [3 ]
Reynolds, Peggy [4 ,5 ]
Nelson, David O. [4 ]
Ziogas, Argyrios [3 ]
Van Den Berg, David [1 ]
Deapen, Dennis M. [1 ]
Bernstein, Leslie [2 ]
Schumacher, Fredrick R. [6 ]
机构：
[1] Univ Southern Calif, Dept Prevent Med, Keck Sch Medicine, Los Angeles, CA USA
[2] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA
[3] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA
[4] Canc Prevent Inst Calif, Berkeley, CA USA
[5] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA
[6] Case Western Reserve Univ, Dept Epidemiol & Biostat, 10900 Euclid Ave, Cleveland, OH 44106 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2017年 / 26卷 / 09期
关键词：
ASSOCIATION; RARE; SUSCEPTIBILITY;
D O I：
10.1158/1055-9965.EPI-17-0364
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Few studies have focused on the relationship of exonic variation with breast cancer and subtypes defined by tumor markers: estrogen receptor (ER), progesterone receptor (PR), and HER2. Methods: Wegenotyped 1,764 breast cancer patients and 1,400 controls from the California Teachers Study cohort using the Infinium HumanExome Beadchip. Individual variant and genebased analyses were conducted for overall breast cancer and by individual tumor marker subtype. Results: No exonic variants or gene-based analyses were statistically significantly associated with breast cancer overall or by ER-, PR-, or HER2-defined subtype. Conclusions: We did not detect any novel statistically significant exonic variants with overall breast cancer risk or by subtype. Impact: Exonic variants in the exome chip may not be associated with overall breast cancer or subtype susceptibility. (C) 2017 AACR.
引用
收藏
页码：1462 / 1465
页数：4
相关论文
共 50 条
  • [41] Genome-wide exploration of genetic interactions for bladder cancer risk
    Yu, Evan Yi-Wen
    Tang, Qiu-Yi
    Chen, Ya-Ting
    Zhang, Yan-Xi
    Dai, Ya-Nan
    Wu, Yu-Xuan
    Li, Wen-Chao
    Mehrkanoon, Siamak
    Wang, Shi-Zhi
    Zeegers, Maurice P.
    Wesselius, Anke
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (01) : 81 - 93
  • [42] Genome-wide Association Study of Prostate Cancer Mortality
    Penney, Kathryn L.
    Pyne, Saumyadipta
    Schumacher, Fredrick R.
    Sinnott, Jennifer A.
    Mucci, Lorelei A.
    Kraft, Peter L.
    Ma, Jing
    Oh, William K.
    Kurth, Tobias
    Kantoff, Philip W.
    Giovannucci, Edward L.
    Stampfer, Meir J.
    Hunter, David J.
    Freedman, Matthew L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (11) : 2869 - 2876
  • [43] Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk
    Willis, Jason A.
    Mukherjee, Semanti
    Orlow, Irene
    Viale, Agnes
    Offit, Kenneth
    Kurtz, Robert C.
    Olson, Sara H.
    Klein, Robert J.
    FRONTIERS IN GENETICS, 2014, 5
  • [44] Genome-wide homozygosity signature and risk of Hodgkin lymphoma
    Sud, Amit
    Cooke, Rosie
    Swerdlow, Anthony J.
    Houlston, Richard S.
    SCIENTIFIC REPORTS, 2015, 5
  • [45] Suggestion of Roles for Both Common and Rare Risk Variants in Genome-wide Studies of Schizophrenia
    Owen, Michael J.
    Craddock, Nick
    O'Donovan, Michael C.
    ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (07) : 667 - 673
  • [46] A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk
    Chapman, Jade
    Rees, Elliott
    Harold, Denise
    Ivanov, Dobril
    Gerrish, Amy
    Sims, Rebecca
    Hollingworth, Paul
    Stretton, Alexandra
    Holmans, Peter
    Owen, Michael J.
    ODonovan, Michael C.
    Williams, Julie
    Kirov, George
    HUMAN MOLECULAR GENETICS, 2013, 22 (04) : 816 - 824
  • [47] Rare Variants Create Synthetic Genome-Wide Associations
    Dickson, Samuel P.
    Wang, Kai
    Krantz, Ian
    Hakonarson, Hakon
    Goldstein, David B.
    PLOS BIOLOGY, 2010, 8 (01)
  • [48] Genome-Wide Analysis of Structural Variants in Parkinson Disease
    Billingsley, Kimberley J.
    Ding, Jinhui
    Jerez, Pilar Alvarez
    Illarionova, Anastasia
    Levine, Kristin
    Grenn, Francis P.
    Makarious, Mary B.
    Moore, Anni
    Vitale, Daniel
    Reed, Xylena
    Hernandez, Dena
    Torkamani, Ali
    Ryten, Mina
    Hardy, John
    Chia, Ruth W.
    Scholz, Sonja J.
    Traynor, Bryan L.
    Dalgard, Clifton J.
    Ehrlich, Debra
    Tanaka, Toshiko
    Ferrucci, Luigi G.
    Beach, Thomas E.
    Serrano, Geidy P.
    Quinn, John J.
    Bubb, Vivien
    Collins, Ryan L.
    Zhao, Xuefang
    Walker, Mark
    Pierce-Hoffman, Emma
    Brand, Harrison E.
    Talkowski, Michael
    Casey, Bradford
    Cookson, Mark R.
    Markham, Androo A.
    Nalls, Mike
    Mahmoud, Medhat
    Sedlazeck, Fritz J.
    Blauwendraat, Cornelis
    Gibbs, J. Raphael B.
    Singleton, Andrew
    ANNALS OF NEUROLOGY, 2023, 93 (05) : 1012 - 1022
  • [49] The limits of genome-wide methods for pharmacogenomic testing
    Gamazon, Eric R.
    Skol, Andrew D.
    Perera, Minoli A.
    PHARMACOGENETICS AND GENOMICS, 2012, 22 (04) : 261 - 272
  • [50] Novel approach to functional SNPs discovery from genome-wide data reveals promising variants for colon cancer risk
    Korbolina, Elena E.
    Brusentsov, Ilja I.
    Bryzgalov, Leonid O.
    Leberfarb, Elena Yu
    Degtyareva, Arina O.
    Merkulova, Tatyana I.
    HUMAN MUTATION, 2018, 39 (06) : 851 - 859
12345